Gene · 386653
Papers2,753
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 2,753
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
IL-31 blockade elevates thymus and activation-regulated chemokine by lifting LAMP3+CD1c+ mature dendritic cells from calcitonin gene-related peptide-calcitonin receptor-like neuroimmune suppression in atopic dermatitis. | J Allergy Clin Immunol | 2026 | 41831623 | PubTator, text mining | PubMed |
| Memory Cells in Atopic Dermatitis: Paving the Way to Disease Modification. | Int J Mol Sci | 2026 | 41828588 | PubTator, text mining | PubMed |
| Profiling of the mycobiome and metabolome: a comparative study of benign pulmonary nodules and lung adenocarcinoma. | Front Cell Infect Microbiol | 2026 | 41809995 | PubTator, text mining | PubMed |
| Correlation between IL-17 levels and chronic urticaria: Systematic review and meta-analysis. | J Allergy Clin Immunol Glob | 2026 | 41809113 | PubTator, text mining | PubMed |
The evaluation of the plasma levels of interleukin 17A, thymic stromal lymphopoietin, interferon gamma, tumor necrosis factor-alpha and interleukins IL-2, IL-6, IL-23, and IL-31 in atopic dermatitis patients with dupilumab treatment. | Front Immunol | 2026 | 41808822 | PubTator, text mining | PubMed |
| Topical and systemic corticosteroids in the modern Management of Atopic Eczema: A scoping review. | Int Immunopharmacol | 2026 | 41802372 | PubTator, text mining | PubMed |
| Acquired reactive perforating collagenosis treated with nemolizumab. | JAAD Case Rep | 2026 | 41799353 | PubTator, text mining | PubMed |
| The role of IL-11 in chronic diseases. | Front Immunol | 2026 | 41789107 | PubTator, text mining | PubMed |
| Association Between Inflammatory Cytokines and Systemic Inflammation Indices in Patients With Psoriasis: A Cross-Sectional Study. | Health Sci Rep | 2026 | 41788642 | PubTator, text mining | PubMed |
| Oncostatin M receptor deficiency as a novel candidate genetic cause of autosomal recessive hyper-IgE syndrome. | J Hum Immun | 2026 | 41783139 | PubTator, text mining | PubMed |
| A Complex Case of Unilateral Stasis Dermatitis With Id Reaction Misdiagnosed as Cellulitis: A Diagnostic Challenge. | Cureus | 2026 | 41777264 | PubTator, text mining | PubMed |
| Differences in Itch Quality Between Interleukin-31 and Thymus and Activation-Regulated Chemokine of Japanese Atopic Dermatitis. | Mayo Clin Proc Innov Qual Outcomes | 2026 | 41769322 | PubTator, text mining | PubMed |
| Case Report: Clinical manifestations reported in a canine after ingesting ruxolitinib phosphate (Opzelura®). | Front Vet Sci | 2026 | 41767678 | PubTator, text mining | PubMed |
| From concept to practice: real-world safety of JAK inhibitors in rheumatoid arthritis treatment. | Front Med (Lausanne) | 2026 | 41767496 | PubTator, text mining | PubMed |
| Multidimensional risk prediction model for infant atopic dermatitis: A prospective cohort study. | World Allergy Organ J | 2026 | 41755993 | PubTator, text mining | PubMed |
| Spatiotemporal Remodeling of Presynaptic Terminals in Human Neuromuscular Junctions. | Int J Mol Sci | 2026 | 41752064 | PubTator, text mining | PubMed |
| Gut-Brain Inflammation and Disrupted Homeostasis Due to Activation of Mast Cells and Microglia. | Int J Mol Sci | 2026 | 41751904 | PubTator, text mining | PubMed |
| Epigenetic Therapies for Inflammatory and Immune-Mediated Skin Diseases. | Biomedicines | 2026 | 41751272 | PubTator, text mining | PubMed |
| Review of Herpes Zoster Occurrence in Patients With Atopic Dermatitis Treated With JAK Inhibitors. | Clin Transl Sci | 2026 | 41748503 | PubTator, text mining | PubMed |
| Proposition for a New Classification of Hypersensitivity Reactions - an Expanded Nomenclature. | Clin Rev Allergy Immunol | 2026 | 41746569 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/386653/papers?page=4